SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,671 | +28.0% | 583 | +21.0% | 0.00% | +100.0% |
| Q2 2023 | $55,199 | -9.2% | 482 | +9.3% | 0.00% | -50.0% |
| Q1 2023 | $60,783 | +22.2% | 441 | +14.8% | 0.00% | +100.0% |
| Q4 2022 | $49,759 | +18.5% | 384 | +2.1% | 0.00% | 0.0% |
| Q3 2022 | $42,000 | +50.0% | 376 | +1.9% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | -3.4% | 369 | -1.1% | 0.00% | 0.0% |
| Q1 2022 | $29,000 | -52.5% | 373 | -45.2% | 0.00% | -50.0% |
| Q4 2021 | $61,000 | -11.6% | 681 | -8.6% | 0.00% | 0.0% |
| Q3 2021 | $69,000 | +32.7% | 745 | +12.4% | 0.00% | 0.0% |
| Q2 2021 | $52,000 | +147.6% | 663 | +136.8% | 0.00% | +100.0% |
| Q1 2021 | $21,000 | +200.0% | 280 | +551.2% | 0.00% | – |
| Q4 2020 | $7,000 | +40.0% | 43 | +10.3% | 0.00% | – |
| Q3 2020 | $5,000 | +25.0% | 39 | +39.3% | 0.00% | – |
| Q2 2020 | $4,000 | +300.0% | 28 | +250.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 8 | +14.3% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 7 | +600.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |